XML 15 R5.htm IDEA: XBRL DOCUMENT v3.20.2
CONSOLIDATED STATEMENTS OF EQUITY - USD ($)
$ in Thousands
Series E Cumulative Redeemable Preferred Stock
Preferred Stock
Series E Cumulative Redeemable Preferred Stock
Cumulative dividends and distributions
Series E Cumulative Redeemable Preferred Stock
Series F Cumulative Redeemable Preferred Stock
Preferred Stock
Series F Cumulative Redeemable Preferred Stock
Cumulative dividends and distributions
Series F Cumulative Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings
Cumulative dividends and distributions
Noncontrolling Interest in Consolidated Joint Venture
Total
Beginning Balance at Dec. 31, 2018 $ 115,000     $ 75,000     $ 2,282 $ 2,728,684 $ 1,182,722 $ (1,440,202) $ 47,685 $ 2,711,171
Beginning Balance (in shares) at Dec. 31, 2018 4,600,000     3,000,000     228,246,247          
Increase (Decrease) in Stockholders' Equity                        
Amortization of deferred stock compensation               2,221       2,221
Issuance of restricted common stock, net             $ 4 (4,439)       (4,435)
Issuance of restricted common stock, net (in shares)             345,132          
Forfeiture of restricted common stock (in shares)             (3,932)          
Common stock distributions and distributions payable                   (11,429)   (11,429)
Preferred stock dividends and dividends payable   $ (1,998) $ (1,998)   $ (1,209) $ (1,209)            
Distributions to noncontrolling interest                     (1,950) (1,950)
Net (loss) income                 16,317   1,599 17,916
Ending Balance at Mar. 31, 2019 $ 115,000     $ 75,000     $ 2,286 2,726,466 1,199,039 (1,454,838) 47,334 2,710,287
Ending Balance (in shares) at Mar. 31, 2019 4,600,000     3,000,000     228,587,447          
Beginning Balance at Dec. 31, 2018 $ 115,000     $ 75,000     $ 2,282 2,728,684 1,182,722 (1,440,202) 47,685 2,711,171
Beginning Balance (in shares) at Dec. 31, 2018 4,600,000     3,000,000     228,246,247          
Increase (Decrease) in Stockholders' Equity                        
Net (loss) income                       97,379
Ending Balance at Sep. 30, 2019 $ 115,000     $ 75,000     $ 2,249 2,681,754 1,274,039 (1,483,907) 48,384 2,712,519
Ending Balance (in shares) at Sep. 30, 2019 4,600,000     3,000,000     224,861,978          
Beginning Balance at Mar. 31, 2019 $ 115,000     $ 75,000     $ 2,286 2,726,466 1,199,039 (1,454,838) 47,334 2,710,287
Beginning Balance (in shares) at Mar. 31, 2019 4,600,000     3,000,000     228,587,447          
Increase (Decrease) in Stockholders' Equity                        
Amortization of deferred stock compensation               3,002       3,002
Issuance of restricted common stock, net (in shares)             51,840          
Common stock distributions and distributions payable                   (11,411)   (11,411)
Preferred stock dividends and dividends payable   (1,998) (1,998)   (1,209) (1,209)            
Distributions to noncontrolling interest                     (788) (788)
Repurchases of outstanding common stock             $ (4) (5,731)       (5,735)
Repurchases of outstanding common stock (in shares)             (432,464)          
Net (loss) income                 43,963   1,955 45,918
Ending Balance at Jun. 30, 2019 $ 115,000     $ 75,000     $ 2,282 2,723,737 1,243,002 (1,469,456) 48,501 2,738,066
Ending Balance (in shares) at Jun. 30, 2019 4,600,000     3,000,000     228,206,823          
Increase (Decrease) in Stockholders' Equity                        
Amortization of deferred stock compensation               2,249       2,249
Common stock distributions and distributions payable                   (11,243)   (11,243)
Preferred stock dividends and dividends payable   (1,998) (1,998)   (1,210) (1,210)            
Distributions to noncontrolling interest                     (2,625) (2,625)
Repurchases of outstanding common stock             $ (33) (44,232)       (44,265)
Repurchases of outstanding common stock (in shares)             (3,344,845)          
Net (loss) income                 31,037   2,508 33,545
Ending Balance at Sep. 30, 2019 $ 115,000     $ 75,000     $ 2,249 2,681,754 1,274,039 (1,483,907) 48,384 2,712,519
Ending Balance (in shares) at Sep. 30, 2019 4,600,000     3,000,000     224,861,978          
Beginning Balance at Dec. 31, 2019 $ 115,000     $ 75,000     $ 2,249 2,683,913 1,318,455 (1,619,779) 46,233 2,621,071
Beginning Balance (in shares) at Dec. 31, 2019 4,600,000     3,000,000     224,855,351          
Increase (Decrease) in Stockholders' Equity                        
Amortization of deferred stock compensation               2,324       2,324
Issuance of restricted common stock, net             $ 4 (3,996)       (3,992)
Issuance of restricted common stock, net (in shares)             456,219          
Forfeiture of restricted common stock (in shares)             (355)          
Common stock distributions and distributions payable                   (10,777)   (10,777)
Preferred stock dividends and dividends payable   (1,998) (1,998)   (1,209) (1,209)            
Distributions to noncontrolling interest                     (2,000) (2,000)
Repurchases of outstanding common stock             $ (98) (103,796)       (103,894)
Repurchases of outstanding common stock (in shares)             (9,770,081)          
Net (loss) income                 (162,061)   (458) (162,519)
Ending Balance at Mar. 31, 2020 $ 115,000     $ 75,000     $ 2,155 2,578,445 1,156,394 (1,633,763) 43,775 2,337,006
Ending Balance (in shares) at Mar. 31, 2020 4,600,000     3,000,000     215,541,134          
Beginning Balance at Dec. 31, 2019 $ 115,000     $ 75,000     $ 2,249 2,683,913 1,318,455 (1,619,779) 46,233 2,621,071
Beginning Balance (in shares) at Dec. 31, 2019 4,600,000     3,000,000     224,855,351          
Increase (Decrease) in Stockholders' Equity                        
Net (loss) income                       (371,126)
Ending Balance at Sep. 30, 2020 $ 115,000     $ 75,000     $ 2,156 2,584,005 951,765 (1,640,178) 40,297 2,128,045
Ending Balance (in shares) at Sep. 30, 2020 4,600,000     3,000,000     215,635,550          
Beginning Balance at Mar. 31, 2020 $ 115,000     $ 75,000     $ 2,155 2,578,445 1,156,394 (1,633,763) 43,775 2,337,006
Beginning Balance (in shares) at Mar. 31, 2020 4,600,000     3,000,000     215,541,134          
Increase (Decrease) in Stockholders' Equity                        
Amortization of deferred stock compensation               3,193       3,193
Issuance of restricted common stock, net             $ 1 (1)        
Issuance of restricted common stock, net (in shares)             94,416          
Preferred stock dividends and dividends payable   (1,998) (1,998)   (1,209) (1,209)            
Contribution from noncontrolling interest                     500 500
Net (loss) income                 (115,338)   (2,162) (117,500)
Ending Balance at Jun. 30, 2020 $ 115,000     $ 75,000     $ 2,156 2,581,637 1,041,056 (1,636,970) 42,113 2,219,992
Ending Balance (in shares) at Jun. 30, 2020 4,600,000     3,000,000     215,635,550          
Increase (Decrease) in Stockholders' Equity                        
Amortization of deferred stock compensation               2,368       2,368
Preferred stock dividends and dividends payable   $ (1,998) $ (1,998)   $ (1,210) $ (1,210)            
Net (loss) income                 (89,291)   (1,816) (91,107)
Ending Balance at Sep. 30, 2020 $ 115,000     $ 75,000     $ 2,156 $ 2,584,005 $ 951,765 $ (1,640,178) $ 40,297 $ 2,128,045
Ending Balance (in shares) at Sep. 30, 2020 4,600,000     3,000,000     215,635,550